跳至主要内容
临床试验/IRCT2016100629884N1
IRCT2016100629884N1已完成2 期

To evaluate the effect of nanomicelle curcumin on the rate of improvement in symptoms of knee osteoarthritis patients

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 65 years(—)
性别
All

入选标准

  • Primary knee osteoarthritis with grade II and III base on Kellgren-Lawrence grading scale; having knee pain at least for six months; age between 45 and 65 years; and having primary osteoarthritis.
  • Exclusion criteria: Secondary osteoarthritis (due to trauma); knee arthroscopic surgery in less than six months; use of corticosteroids less than six months; history of allergy; coagulation disorders and coronary heart disease; use of medications affecting coagulation process (e.g., warfarin, heparin, clopidogrel, dipyridamole, and aspirin); genu varum, genu valgus, and pes planus patients; and patients with anserine bursitis

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验